Severe subconjunctival bleeding in a patient with concomitant use of warfarin and valproic acid
DOI:
https://doi.org/10.2478/AMB-2024-0024Keywords:
warfarin, divalproex acid, subconjunctival bleeding, strokeAbstract
Drug interactions with vitamin K antagonist may involve antiepileptic drug. Numerous antiepileptic drugs are strong inducers or inhibitors of liver enzymes and affect warfarin metabolism, including valproic acid, which is capable of displacing warfarin from
the protein binding site. Although this type of drug interaction is less widely recognized, it is a phenomenon that causes significant changes in the INR. We report a case of severe subconjunctival bleeding in patient with concomitant use of warfarin and valproic acid. The management include cessation of the drug, conservative eye treatment, and vitamin K. The case was fully resolved.
References
Yoon HW, Giraldo EA, Wijdicks EF. Valproic acid and warfarin: an underrecognized drug interaction. Neurocrit Care. 2011 Aug; 15(1):182-5. doi: 10.1007/s12028-011-9544-5.
Zhou C, Sui Y, Zhao W, et al. The critical interaction between valproate sodium and warfarin: case report and review. BMC Pharmacol Toxicol. 2018 Oct 1; 19(1):60. doi: 10.1186/s40360-018-0251-0.
Anderson SL, Marrs JC. Probable Interaction Between Warfarin and Divalproex Sodium. J Pharm Technol. 2014 Feb; 30(1):8-12. doi:10.1177/8755122513514379. Epub 2013 Nov 22.
Bruun E, Virta LJ, Kalviainen R, et al. Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy. Epilepsy Behav. 2017; 73:71–76. doi: 10.1016/j.yebeh.2017.05.022.
Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. LancetNeurol. 2003; 2(6):347-356. doi: 10.1016/S1474-4422(03)00409-5.
Cun-Li Wang, Victor Chien-Chia Wu, Kuo-Hsuan Chang, et al. Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs, European Heart Journal - Cardiovascular Pharmacotherapy, May 2020, 6 (3): 147-154.
Kouchaki B, Salehifar E, Janbabai G, et al. Major Interaction between Warfarin and Na Valproate: A Case Report. J Pharm Care 2014; 2 (4): 183-185.
Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 2003; 42:123-37.
Zeller JA, Schlesinger S, Runge U, et al. Influence of valproate monotherapy on platelet activation and hematologic values. Epilepsia 1999; 40: 186-9.
Jimenez-Ruiz A, Gutierrez-Castillo A, Ruiz-Sandoval JL. Fatal Intracranial Hemorrhage Associated with Oral Warfarin Use. Cureus. 2018 Nov 12; 10(11):e3571. doi:10.7759/cureus.3571.
Teo KC, Mahboobani NR, Lee R, et al. Warfarin associated intracerebral hemorrhage in Hong Kong Chinese. Neurol Res. 2014 Feb; 36(2):143-9. doi:10.1179/1743132813Y.0000000275. Epub 2013 Dec 6.
Morotti A, Goldstein, J. N. Anticoagulant-Associated Intracerebral Hemorrhage. Brain Hemorrhages. 2020, 1(1), 89-94.
doi:10.1016/j.hest.2020.01.001
Downloads
Published
Issue
Section
License
Copyright (c) 2024 R.T. Pinzonindo, M. Afifudin, A. Digdoyo (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
